Western medicine composition for treating liver cancer
A technology for the treatment of liver cancer and compositions, applied in the directions of drug combinations, active ingredients of heterocyclic compounds, anti-tumor drugs, etc., can solve the problems of immune function suppression, physical damage of patients, killing of normal cells, etc., achieve stable properties, reduce side effects, The effect of promoting drug metabolism
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0020] A western medicine composition for treating liver cancer, which consists of the following components: norcantharidin 3.9mg, chlorooxyquine 80.2mg, mannan peptide 6.3mg, hydrous lactose 4.8mg, magnesium stearate 2.7mg, microcrystalline fiber Cantharidin 3.1mg, pregelatinized starch 4.0mg, starch 15.0mg, wherein, norcantharidin, chloroxyquine, mannan peptide are drug components.
Embodiment 2
[0022] A western medicine composition for treating liver cancer, which consists of the following components: norcantharidin 3.2mg, chlorooxyquine 89.3mg, mannan peptide 3.4mg, hydrous lactose 5.2mg, magnesium stearate 2.5mg, microcrystalline fiber Cantharidin 4.2mg, pregelatinized starch 3.7mg, starch 8.5mg, wherein, norcantharidin, chloroxyquine, mannan peptide are drug components.
Embodiment 3
[0024] A western medicine composition for treating liver cancer, which consists of the following components: norcantharidin 4.8mg, chlorooxyquine 75.5mg, mannan peptide 8.6mg, hydrous lactose 3.4mg, magnesium stearate 3.6mg, microcrystalline fiber Cantharidin 2.8mg, pregelatinized starch 4.6mg, starch 16.7mg, wherein, norcantharidin, chloroxyquine, mannan peptide are drug components.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More